Cargando…
HMGB1 bound to cisplatin–DNA adducts undergoes extensive acetylation and phosphorylation in vivo
Cisplatin, one of the most effective anticancer drugs, is a DNA-damaging agent that induces cell death primarily by apoptosis. For many years, HMGB1 has been known to be a recognition protein for cisplatin–DNA lesions. Here, an application of a biomolecular probe based on a peptide–oligonucleotide c...
Autores principales: | He, Yafeng, Ding, Yin, Wang, Dan, Zhang, Wanjun, Chen, Weizhong, Liu, Xichun, Qin, Weijie, Qian, Xiaohong, Chen, Hao, Guo, Zijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810237/ https://www.ncbi.nlm.nih.gov/pubmed/29449921 http://dx.doi.org/10.1039/c4sc03650f |
Ejemplares similares
-
Effects of mimicked acetylated HMGB1 on macrophages and dendritic cells
por: Chen, Xiaohong, et al.
Publicado: (2018) -
Detection and Characterization of Single Cisplatin
Adducts on DNA by Nanopore Sequencing
por: Zhao, Xinjia, et al.
Publicado: (2021) -
Cisplatin adducts of DNA as precursors for nanostructured catalyst materials
por: Englert, Klaudia, et al.
Publicado: (2020) -
Double Diapering Ineffectiveness in Avoiding Adduction and Extension in Newborns Hips
por: De Pellegrin, Maurizio, et al.
Publicado: (2021) -
Characterization of N-Acetyl Cysteine Adducts with Exogenous and Neutrophil-Derived 2-Chlorofatty Aldehyde
por: Shakya, Shubha, et al.
Publicado: (2023)